HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Pan Selected Research

Glucose Oxidase

6/2022An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy.
6/2021An enzyme nanopocket based on covalent organic frameworks for long-term starvation therapy and enhanced photodynamic therapy of cancer.
5/2021A dual-catalytic nanoreactor for synergistic chemodynamic-starvation therapy toward tumor metastasis suppression.
1/2020Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
11/2018A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Pan Research Topics

Disease

104Neoplasms (Cancer)
10/2022 - 01/2000
35Infections
08/2022 - 12/2000
26Inflammation (Inflammations)
08/2022 - 10/2006
15Myocardial Infarction
04/2021 - 09/2004
14Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2004
12Breast Neoplasms (Breast Cancer)
12/2021 - 10/2008
10Heart Failure
01/2022 - 08/2005
9Cognitive Dysfunction
11/2021 - 11/2018
9Neurodegenerative Diseases (Neurodegenerative Disease)
11/2021 - 02/2003
8Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2015
8Obesity
01/2022 - 03/2006
7Neoplasm Metastasis (Metastasis)
05/2021 - 01/2014
7Stroke (Strokes)
05/2019 - 09/2004
6Starvation
06/2022 - 11/2018
6Leukemia
03/2022 - 01/2017
6Atherosclerosis
01/2022 - 05/2014
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2006
6Osteosarcoma (Osteogenic Sarcoma)
02/2018 - 01/2014
6Renal Insufficiency (Renal Failure)
04/2017 - 01/2009
5Insulin Resistance
01/2022 - 11/2012
5Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2013
5Neuroinflammatory Diseases
11/2021 - 01/2016
5Hypertrophy
10/2021 - 01/2013
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 08/2005
4Liver Neoplasms (Liver Cancer)
01/2022 - 05/2004
4Lung Neoplasms (Lung Cancer)
11/2021 - 01/2000
4Hypoxia (Hypoxemia)
04/2021 - 06/2019
4Macular Degeneration (Age-Related Maculopathy)
01/2021 - 06/2018
4Pain (Aches)
01/2021 - 09/2016
4Thrombosis (Thrombus)
01/2018 - 11/2007
4Neuralgia (Stump Neuralgia)
01/2018 - 01/2017
4ST Elevation Myocardial Infarction
01/2018 - 10/2010
4Vesicular Stomatitis
12/2017 - 03/2008
3Syndrome (Syndromes)
03/2022 - 10/2019
3Reperfusion Injury
01/2022 - 05/2009
3Fibrosis (Cirrhosis)
01/2022 - 10/2021
3Virus Diseases (Viral Diseases)
11/2021 - 09/2015
3Infertility (Sterility)
01/2021 - 10/2019
3Atrophy
01/2021 - 01/2019
3Sepsis (Septicemia)
01/2021 - 01/2014
3Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020 - 01/2017
3Tuberculosis (Tuberculoses)
08/2020 - 10/2002

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
11/2021 - 05/2004
20Pharmaceutical PreparationsIBA
10/2022 - 01/2000
19Messenger RNA (mRNA)IBA
01/2021 - 05/2009
14Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2018
14MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
12Biological ProductsIBA
07/2022 - 05/2004
12DNA (Deoxyribonucleic Acid)IBA
07/2022 - 10/2006
11Therapeutic UsesIBA
07/2022 - 07/2013
11Biomarkers (Surrogate Marker)IBA
07/2020 - 11/2013
11Retinaldehyde (Retinal)IBA
01/2020 - 01/2017
10Metal-Organic FrameworksIBA
07/2022 - 06/2019
10Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 04/2015
7EnzymesIBA
05/2022 - 07/2017
7LipidsIBA
01/2022 - 02/2009
6CytokinesIBA
01/2022 - 10/2006
61-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2021 - 11/2015
6VaccinesIBA
12/2020 - 04/2012
6AntigensIBA
09/2020 - 01/2015
6Long Noncoding RNAIBA
01/2020 - 05/2014
6Small Interfering RNA (siRNA)IBA
11/2018 - 08/2004
6Complementary DNA (cDNA)IBA
02/2016 - 01/2000
5Glucose OxidaseIBA
06/2022 - 11/2018
5InterleukinsIBA
05/2021 - 01/2015
5Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 02/2003
5Photosensitizing Agents (Photosensitizers)IBA
01/2021 - 11/2015
4oxidized low density lipoproteinIBA
01/2022 - 09/2016
4Peptides (Polypeptides)IBA
01/2022 - 05/2017
4Antiviral Agents (Antivirals)IBA
01/2021 - 01/2015
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2018
4Indicators and Reagents (Reagents)IBA
01/2020 - 01/2014
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2010 - 09/2004
3ProdrugsIBA
08/2022 - 01/2021
3polyene phosphatidylcholineIBA
08/2022 - 01/2017
3Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 09/2007
3Triglycerides (Triacylglycerol)IBA
01/2022 - 07/2019
3HDL CholesterolIBA
01/2022 - 07/2019
3Nucleic AcidsIBA
11/2021 - 05/2015
3PorphyrinsIBA
06/2021 - 07/2020
3Immunologic Factors (Immunomodulators)IBA
02/2021 - 12/2020
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 07/2008
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021 - 03/2010
3Oxygen (Dioxygen)IBA
01/2021 - 04/2019
3LipopolysaccharidesIBA
01/2021 - 01/2016
3TensinsIBA
01/2021 - 03/2010

Therapy/Procedure

81Therapeutics
08/2022 - 08/2003
11Photochemotherapy (Photodynamic Therapy)
08/2022 - 11/2015
9Drug Therapy (Chemotherapy)
01/2022 - 01/2014
9Radiotherapy
09/2020 - 01/2017
8Percutaneous Coronary Intervention
01/2018 - 11/2007
7Immunotherapy
07/2022 - 06/2020
7Photothermal Therapy
11/2021 - 07/2017
6Lasers (Laser)
11/2021 - 01/2018
6Length of Stay
01/2021 - 01/2009
5Cardiopulmonary Bypass (Heart-Lung Bypass)
04/2014 - 06/2005
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2014 - 03/2006
3Aftercare (After-Treatment)
03/2022 - 11/2005
3Artificial Respiration (Mechanical Ventilation)
06/2021 - 01/2020
3Precision Medicine
01/2021 - 07/2017